Methods of blocking cancer stem cell growth
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
Mar 24, 2020
Grant Date -
Sep 11, 2014
app pub date -
Oct 31, 2012
filing date -
Oct 31, 2012
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed herein are antibodies against GPR49 and uses of such antibodies. The antibodies can be monoclonal, humanized, or fully human antibodies against GPR49, hybridomas or other cell lines expressing such antibodies, nucleic acids and vectors comprising nucleic acids encoding for such antibodies, and methods of blocking cancer stem cell growth with such antibodies.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully